DNM2 and cardiomyopathy: So, the cytoskeletal protein network of the cardiac myocytes modulates the L-type Ca2+ channel, which, in turn, regulates mitochondrial function, opening other perspectives to test new experiments on possible future therapies for preventing cardiomyopathies [140].